Attributes | Values |
---|
rdf:type
| |
Description
| - Proteomic profiling of cancer cells was carried out with a view to adressing leukemia and its treatment with perspective towards novel diagnostic and / or treatment modalities. Advances in cancer therapeutics and challenges for better patient outcome has lead to demands for individualised or personalised therapy and targeting of tumors for a better outcome. earlier protein changes that precede the on-set of apoptosis or changes in post-translational modifications were studied using proteomic analysis of cells treated with anti-cancer drug Cis-platin. To reliably quantify maximum number of proteins in the whole cell lysate, combination of three proteomic methodologies namely 2-DE electrophoresis, PF 2D liquid chromatography and SILAC were used
- Proteomic profiling of cancer cells was carried out with a view to adressing leukemia and its treatment with perspective towards novel diagnostic and / or treatment modalities. Advances in cancer therapeutics and challenges for better patient outcome has lead to demands for individualised or personalised therapy and targeting of tumors for a better outcome. earlier protein changes that precede the on-set of apoptosis or changes in post-translational modifications were studied using proteomic analysis of cells treated with anti-cancer drug Cis-platin. To reliably quantify maximum number of proteins in the whole cell lysate, combination of three proteomic methodologies namely 2-DE electrophoresis, PF 2D liquid chromatography and SILAC were used (en)
|
Title
| - Effect of anti-cancer drug cis-platin on leukemia cells-protein profiling using three independent analytical techniques
- Effect of anti-cancer drug cis-platin on leukemia cells-protein profiling using three independent analytical techniques (en)
|
skos:prefLabel
| - Effect of anti-cancer drug cis-platin on leukemia cells-protein profiling using three independent analytical techniques
- Effect of anti-cancer drug cis-platin on leukemia cells-protein profiling using three independent analytical techniques (en)
|
skos:notation
| - RIV/67985904:_____/09:00338290!RIV10-MSM-67985904
|
http://linked.open...avai/riv/aktivita
| |
http://linked.open...avai/riv/aktivity
| - P(LC07017), Z(AV0Z50200510), Z(AV0Z50450515)
|
http://linked.open...vai/riv/dodaniDat
| |
http://linked.open...aciTvurceVysledku
| |
http://linked.open.../riv/druhVysledku
| |
http://linked.open...iv/duvernostUdaju
| |
http://linked.open...titaPredkladatele
| |
http://linked.open...dnocenehoVysledku
| |
http://linked.open...ai/riv/idVysledku
| - RIV/67985904:_____/09:00338290
|
http://linked.open...riv/jazykVysledku
| |
http://linked.open.../riv/klicovaSlova
| - Cis-platin; CEM T-lymphoblastic leukemia; 2D-electrophoresis (en)
|
http://linked.open.../riv/klicoveSlovo
| |
http://linked.open...ontrolniKodProRIV
| |
http://linked.open...v/mistoKonaniAkce
| |
http://linked.open...i/riv/mistoVydani
| |
http://linked.open...i/riv/nazevZdroje
| - 3rd EuPA Congress Clinical Proteomics
|
http://linked.open...in/vavai/riv/obor
| |
http://linked.open...ichTvurcuVysledku
| |
http://linked.open...cetTvurcuVysledku
| |
http://linked.open...vavai/riv/projekt
| |
http://linked.open...UplatneniVysledku
| |
http://linked.open...iv/tvurceVysledku
| - Man, Petr
- Novák, Petr
- Gadher, S. J.
- Havlíček, Vladimír
- Hrabáková, Rita
- Kovářová, Hana
- Skalníková, Helena
- Pompach, Petr
- Hajduch, M.
- Strohalm, Martin
- Džubák, P.
- Martinková, Jiřina
|
http://linked.open...vavai/riv/typAkce
| |
http://linked.open.../riv/zahajeniAkce
| |
http://linked.open...n/vavai/riv/zamer
| |
number of pages
| |
http://purl.org/ne...btex#hasPublisher
| |
https://schema.org/isbn
| |